Combination chemotherapy with folate antagonists.
D000328:Adult; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D000963:Antimetabolites / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001215:Asparaginase / Q000627:therapeutic use; D002648:Child; D004338:Drug Combinations; D004347:Drug Interactions; D004357:Drug Synergism; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D006801:Humans; D007279:Injections, Subcutaneous; D002955:Leucovorin / Q000627:therapeutic use; D007939:Leukemia L1210 / Q000188:drug therapy; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D051379:Mice; D008815:Mice, Inbred Strains; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D013997:Time Factors
D000903:Antibiotics, Antineoplastic; D000963:Antimetabolites; D000970:Antineoplastic Agents; D004338:Drug Combinations; D005493:Folic Acid Antagonists; D009588:Nitrogen Mustard Compounds; D001215:Asparaginase; D002955:Leucovorin; D011241:Prednisone; D008727:Methotrexate